ISSN: 2278-0238

Международный журнал исследований и разработок в области фармации и наук о жизни

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Абстрактный

FORMULATION AND EVALUATION OF NANOPARTICLES CONTAINING ARTEMISININ HCL

Gupta Dilip Kumar, Razdan B.K., Bajpai Meenakshi

The present study deals with the formulation and evaluation of Artemisinin HCl nanoparticles. Artemisinin is a sesquiterpene lactone chemical extract from Artemisia annua (sweet wormwood), is poorly soluble in water and a fast-acting blood schizonticide effective in treating the acute attack of malaria (including chloroquine – resistant and celebral malaria). Artemisinin are effective against multi-resistant strains of P. falciparum. The purpose of the present work is to minimize the dosing frequency, taste masking and toxicity and to improve the therapeutic efficacy by formulating Artemisinin HCl nanoparticles. Artemisinin HCl nanoparticles were formulated by solvent evaporation method using polymer poly(ε-caprolactone) with five different formulations. Nanoparticles were characterized by determining its particle size, polydispersity index, drug entrapment efficiency, particle morphological character and drug release. The particle size ranged between 100nm to 240nm. Drug entrapment efficacy was > 99%. The in-vitro release of nanoparticles were carried out which exhibited a sustained release of Artemisinin HCl from nanoparticles up to 24hrs. The results showed that nanoparticles can be a promising drug delivery system for sustained release of Artemisinin HCl.